Saturday, 17 November 2012

Readout of the President’s Phone Call with Turkish Prime Minister Erdogan

Today, the President called Prime Minister Erdogan to discuss the escalating violence in Israel and the Gaza Strip.  The two leaders shared their concerns about the dangers to civilian populations on both sides and expressed their common desire to see an end to the violence.  The President and Prime Minister agreed that the continued spiral of violence jeopardizes prospects for a durable, lasting peace in the region.  The President underscored his commitment to advancing the goal of Middle East peace. The President’s call to Prime Minister Erdogan follows his outreach to counterparts in Israel and Egypt on November 14.

Source: http://www.whitehouse.gov/the-press-office/2012/11/16/readout-president-s-phone-call-turkish-prime-minister-erdogan

Donna Feldman Drea de Matteo Drew Barrymore Ehrinn Cummings Elena Lyons

Thyrotoxic Myopathy

Thyrotoxic Myopathy information sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS).

Source: http://www.ninds.nih.gov/disorders/thyrotoxic_myopathy/thyrotoxic_myopathy.htm

Brody Dalle Brooke Burke Brooke Burns Busy Philipps Cameron Diaz

Post-Polio Syndrome

Post-Polio syndrome information compiled by the National Institute of Neurological Disorders and Stroke (NINDS).

Source: http://www.ninds.nih.gov/disorders/post_polio/post_polio.htm

Anna Paquin AnnaLynne McCord Anne Marie Kortright April Scott Arielle Kebbel

Friday, 16 November 2012

Inverse Agonists of the TSH Receptor for the Treatment of Thyroid Cancer and Hyperthyroidism

This technology features small molecule inverse agonists of the thyroid-stimulating hormone (TSH) receptor that may be readily synthesized, and are likely to prove effective for oral administration. These compounds may potentially be used to treat recurrent thyroid cancer and some cases of hyperthyroidism, and also represent unique tools for investigating the role of TSH receptor signaling in these diseases.

According to the National Cancer Institute, over 37,000 new cases of thyroid cancer were diagnosed in the United States in 2008. Approximately 10% to 30% of patients thought to be disease-free after initial treatment will develop recurrent cancer or metastases, and unless the recurrence is detected early, the prognosis is generally poor.

As the TSH receptor is known to stimulate proliferation of thyroid cancer cells, it has been suggested that suppression of basal TSH receptor signaling may improve outcomes in the treatment of recurrent thyroid cancer. The compounds disclosed in this technology suppress basal signaling by the TSH receptor, and are thus excellent candidates for a suppression-based treatment approach. CRADA Opportunity: The NIDDK Office of Technology Transfer and Development is seeking statements of capability or interest from parties interested in collaborative research to further develop inverse agonists of the TAS receptor. Please contact Marguerite J. Miller at 301-496-9003 or millermarg@mail.nih.gov for more information.

Source: http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=2172

Audrina Patridge Autumn Reeser Avril Lavigne Bali Rodriguez Bar Refaeli

Training in Basic Biomethodology for Laboratory Rats

The National Human Genome Research Institute Office of Laboratory Animal Medicine, with support from the NIH Office of Animal Care and Use and the AALAS Foundation, has developed a training CD in "Basic Biomethodology for Laboratory Rats". To obtain a copy of the CD send your name, research institution affiliation, full mailing address and email address to rats_cd@mail.nih.gov. One CD per request please.

Source: http://grants.nih.gov/grants/olaw/newsarchive_2009.htm#20091204

Emmy Rossum Erica Leerhsen Erika Christensen Estella Warren Eva Green

Final Cut Pro X, Motion 5, Compressor 4: Issue when sharing a project to Vimeo with an ampersand (&) in the title

If you share a Project to Vimeo that has an ampersand (&) in the name of the project, the title may be shortened. The title of the video on Vimeo will only include the part of the project title before the ampersand.

Source: http://support.apple.com/kb/TS4454

Jennifer Gimenez Jennifer Love Hewitt Jennifer Morrison Jennifer ODell Jennifer Scholle

New Cholera Vaccine and Method for Conjugating Bacterial Polysaccharides to Proteins

A new conjugate vaccine for cholera has been developed. The invention includes a new method to conjugate the O-specific polysaccharide-core part of the bacterial lipopolysaccharide and protein subcomponents. Conventional technology has entailed chemical treatment of both components to introduce linkers, which made them amenable for covalent linking. The new method simplifies production by utilizing squaric acid chemistry for conjugating the free amine-containing species (e.g. polysaccharides) directly to amine-containing species (e.g. proteins) without prior modification of either component. While demonstrated in this new cholera prototype vaccine, the technology is envisioned as generally applicable, thereby streamlining a complex production process.

CRADA Opportunity: The National Institute of Diabetes and Digestive and Kidney Diseases is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize conjugate vaccines. For collaboration opportunities, please contact Marguerite J. Miller, M.B.A. at 301-496-9003 or millermarg@niddk.nih.gov.

Source: http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=2349

Jennifer Morrison Jennifer ODell Jennifer Scholle Jennifer Sky Jenny McCarthy